The Enterprise Value as of November 2024 (TTM) for ProQR Therapeutics N.V. (PRQR) is 286.46M

According to ProQR Therapeutics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 286.46M. This represents a change of 329.62% compared to the average of 66.68M of the last 4 quarters.

ProQR Therapeutics N.V. (PRQR) Historical Enterprise Value (quarterly & annually)

How has PRQR Enterprise Value performed in the past?

The mean historical Enterprise Value of ProQR Therapeutics N.V. over the last ten years is 158.19M. The current 286.46M Enterprise Value has changed 18.01% with respect to the historical average. Over the past ten years (40 quarters), PRQR's Enterprise Value was at its highest in in the September 2018 quarter at 476.92M. The Enterprise Value was at its lowest in in the March 2022 quarter at -48810476.85.

ProQR Therapeutics N.V. (PRQR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ProQR Therapeutics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProQR Therapeutics N.V. (PRQR) Average Enterprise Value

How has PRQR Enterprise Value performed in the past?

The current Enterprise Value of ProQR Therapeutics N.V. (PRQR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ProQR Therapeutics N.V. (PRQR) Enterprise Value vs. Peers

How is PRQR’s Enterprise Value compared to its peers?

ProQR Therapeutics N.V.’s Enterprise Value is less than Annexon, Inc. (497.96M), less than Arrowhead Pharmaceuticals, Inc. (2.69B), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than Terns Pharmaceuticals, Inc. (222.97M), less than Alnylam Pharmaceuticals, Inc. (31.79B), less than Wave Life Sciences Ltd. (1.89B), less than Blueprint Medicines Corporation (6.36B), less than Apellis Pharmaceuticals, Inc. (3.90B), greater than Assembly Biosciences, Inc. (68.59M), greater than Spero Therapeutics, Inc. (-8426888.00), greater than Achilles Therapeutics plc (-38865958.00), greater than Instil Bio, Inc. (165.40M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than CytomX Therapeutics, Inc. (39.67M), greater than NextCure, Inc. (11.01M), less than Nuvation Bio Inc. (923.54M),

Build a custom stock screener for ProQR Therapeutics N.V. (PRQR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProQR Therapeutics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProQR Therapeutics N.V. (PRQR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProQR Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.